Reuters
Beijing-based TravelSky Technology Ltd is advising its employees to take a candidate vaccine being developed by China National Pharmaceutical Group (Sinopharm) amid the capital’s latest COVID-19 flare-up, state newspaper Global Times reported. No vaccine has yet been proven to effectively protect people from the disease caused by the novel coronavirus that has killed more than 400,000 people globally, but multiple candidates are in development. TravelSky Technology, controlled by state-owned China TravelSky Holding Company, is the country’s dominant provider of information technology to the air travel and tourism industries.